![](/img/cover-not-exists.png)
Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma
Sorigue, Marc, Bishton, Mark, Domingo-Domenech, Eva, McMillan, Andrew, Prusila, Roosa, García, Olga, Kuusisto, Milla, Condom, Maria, Tapia, Gustavo, Ribera, Josep-María, Kuittinen, Outi, Fox, ChristopJournal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2019.1594212
Date:
April, 2019
File:
PDF, 1.14 MB
2019